These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23546443)

  • 1. Atrial fibrillation: Anticoagulation for AF: can we GRASP-AF patients?
    Lane DA; Lip GY
    Nat Rev Cardiol; 2013 May; 10(5):241-2. PubMed ID: 23546443
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectively Initiating and Maintaining Anticoagulation in Patients With Atrial Fibrillation.
    Wang TY
    Circulation; 2019 Apr; 139(15):1763-1765. PubMed ID: 30958715
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's New in Anticoagulation.
    Razavi JE; Safavi-Naeini P; Razavi M
    Tex Heart Inst J; 2016 Oct; 43(5):419-421. PubMed ID: 27777526
    [No Abstract]   [Full Text] [Related]  

  • 5. Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.
    Deitelzweig S
    Cardiovasc Ther; 2014 Apr; 32(2):74-81. PubMed ID: 24119252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation of elderly patients at high risk for falls with atrial fibrillation.
    Med Lett Drugs Ther; 2017 Feb; 59(1515):35-36. PubMed ID: 28222062
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.
    Di Biase L
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892528
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
    Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MY APPROACH to the practical management of anticoagulation in patients with atrial fibrillation.
    Flaker G
    Trends Cardiovasc Med; 2016 Apr; 26(3):292. PubMed ID: 26874917
    [No Abstract]   [Full Text] [Related]  

  • 11. Which oral anticoagulant for atrial fibrillation.
    Med Lett Drugs Ther; 2016 Apr; 58(1492):45-6. PubMed ID: 27049507
    [No Abstract]   [Full Text] [Related]  

  • 12. Edoxaban in venous thromboembolism and stroke prevention: an appraisal.
    Proietti M; Lip GY
    Vasc Health Risk Manag; 2016; 12():45-51. PubMed ID: 27013883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation.
    Boriani G; Pettorelli D
    Vascul Pharmacol; 2016 Aug; 83():26-35. PubMed ID: 27196706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.
    Wehbe RM; Yadlapati A
    Tex Heart Inst J; 2016 Aug; 43(4):287-90. PubMed ID: 27547134
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
    Lip GY; Bongiorni MG; Dobreanu D; Lewalter T; Hastrup Svendsen J; Blomström-Lundqvist C;
    Europace; 2013 Oct; 15(10):1526-32. PubMed ID: 24072770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.
    Cloutier JM; Khoo C; Hiebert B; Wassef A; Seifer CM
    Ther Adv Cardiovasc Dis; 2018 Apr; 12(4):113-122. PubMed ID: 29528778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients.
    Dillinger JG; Aleil B; Cheggour S; Benhamou Y; Béjot Y; Marechaux S; Delluc A; Bertoletti L; Lellouche N
    Arch Cardiovasc Dis; 2018 Feb; 111(2):85-94. PubMed ID: 28988597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel oral anticoagulants to prevent stroke in atrial fibrillation.
    Verheugt FW
    Nat Rev Cardiol; 2010 Mar; 7(3):149-54. PubMed ID: 20179722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Thinners for Atrial Fibrillation Stroke Prevention.
    Pundi K; Baykaner T; True Hills M; Lin B; Morin DP; Sears SF; Wang PJ; Stafford RS
    Circ Arrhythm Electrophysiol; 2021 Jun; 14(6):e009389. PubMed ID: 34111936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.